Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation

BACKGROUND: Subclinical atrial fibrillation (SCAF) is often asymptomatic nonetheless harmful. In patients with cardiac implantable electronic devices, we evaluated the combined performance of homocysteine and uric acid (UA) biomarkers to discriminate high‐risk patients for SCAF. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shihao, Wei, Yushan, Hidru, Tesfaldet Habtemariam, Li, Daobo, Wang, Nan, Yang, Yiheng, Wang, Yunsong, Yang, Xiaolei, Xia, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075184/
https://www.ncbi.nlm.nih.gov/pubmed/34971315
http://dx.doi.org/10.1161/JAHA.121.021997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075184/
https://www.ncbi.nlm.nih.gov/pubmed/34971315
http://dx.doi.org/10.1161/JAHA.121.021997

Ejemplares similares